GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters

被引:0
|
作者
Carolin Gabbert
Susen Schaake
Theresa Lüth
Christoph Much
Christine Klein
Jan O. Aasly
Matthew J. Farrer
Joanne Trinh
机构
[1] University of Lübeck,Institute of Neurogenetics
[2] Norwegian University of Science and Technology,Department of Neuromedicine and Movement Science
[3] University of Florida,Department of Neurology
来源
BMC Genomics | / 24卷
关键词
Parkinson’s disease; Variants; Nanopore sequencing; Risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?
    Surface, Matthew
    Balwani, Manisha
    Waters, Cheryl
    Haimovich, Alexander
    Gan-Or, Ziv
    Marder, Karen S.
    Hsieh, Tammy
    Song, Linxia
    Padmanabhan, Shalini
    Hsieh, Frank
    Merchant, Kalpana M.
    Alcalay, Roy N.
    MOVEMENT DISORDERS, 2022, 37 (08) : 1782 - 1782
  • [32] Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson’s disease
    Yangjie Zhou
    Yige Wang
    Juan Wan
    Yuwen Zhao
    Hongxu Pan
    Qian Zeng
    Xun Zhou
    Runcheng He
    Xiaoxia Zhou
    Yaqin Xiang
    Zhou Zhou
    Bin Chen
    Qiying Sun
    Qian Xu
    Jieqiong Tan
    Lu Shen
    Hong Jiang
    Xinxiang Yan
    Jinchen Li
    Jifeng Guo
    Beisha Tang
    Heng Wu
    Zhenhua Liu
    npj Parkinson's Disease, 9
  • [33] Sex Distribution of GBA1 Variants Carriers with Dementia with Lewy Bodies and Parkinson's Disease
    Toffoli, Marco
    Schapira, Anthony H. V.
    Proukakis, Christos
    MOVEMENT DISORDERS, 2023, 38 (11) : 2137 - 2139
  • [34] Contrasting Olfactory Perception in Parkinson's disease (PD): Impact of GBA1 Gene Mutations
    Schechter, Y.
    Dominko, M.
    Cohen, M.
    Yahalom, G.
    Zimran, A.
    Revel-Vilk, S.
    Shulman, E.
    Dinur, T.
    Cohen, M. Becker
    MOVEMENT DISORDERS, 2024, 39 : S140 - S140
  • [35] Lack of full sequencing GBA1 studies for patients with Parkinson’s disease in Latin America
    Bruno Lopes Santos-Lobato
    Artur F. Schumacher-Schuh
    Ignacio F. Mata
    npj Parkinson's Disease, 8
  • [36] Lack of full sequencing GBA1 studies for patients with Parkinson's disease in Latin America
    Lopes Santos-Lobato, Bruno
    Schumacher-Schuh, Artur F.
    Mata, Ignacio F.
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [37] Mapping the GBA1 gene rare variants and their effects in a Hungarian Parkinson's Disease Cohort
    Szlepak, Tamas
    Kossev, Annabel Plamen
    Csaban, Dora
    Illes, Anett
    Borsos, Beata
    Balicza, Peter
    Grosz, Zoltan
    Takats, Annamaria
    Klivenyi, Peter
    Molnar, Maria Judit
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 297 - 297
  • [38] Generation of GBA1 isogenic iPSC lines to investigate the pathogenesis of GBA1-associated Parkinson disease
    Ma, Charis
    Chen, Yu
    Chen, Chase
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [39] The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson's Disease: a New Genetic State of the Art
    dos Santos, Julio Cesar Claudino
    Mano, Gabriela Braga Cabrera
    da Cunha Barreto-Vianna, Andre Rodrigues
    Garcia, Tulia Fernanda Meira
    de Vasconcelos, Aline Vieira
    Sa, Caio Sergio Gomes
    de Souza Santana, Sarah Lopes
    Farias, Ana Gabriela Ponte
    Seimaru, Beatriz
    Lima, Micael Porto Portela
    Goes, Joao Vitor Caetano
    Gusmao, Camilla Teixeira Pinheiro
    Ribeiro Junior, Howard Lopes
    MOLECULAR NEUROBIOLOGY, 2024, 61 (09) : 6754 - 6770
  • [40] The Functional Consequences of the 'African GBA1 Allele' of rs3115534 in Parkinson's disease (PD)
    Radefeldt, M.
    Demuth, L.
    Al-Ali, R.
    Fischer, S.
    Beetz, C.
    Bauer, P.
    MOVEMENT DISORDERS, 2024, 39 : S750 - S750